Covid-19 roundup: HHS may strug­gle to ab­sorb Op­er­a­tion Warp Speed; Eu­rope has no plans for a fourth vac­cine dose

4 years ago
Coronavirus

Mer­ck wins le­gal bat­tle over in­sur­ance cov­er­age af­ter ran­somware at­tack

4 years ago
Pharma

Flori­da man con­vict­ed of fal­si­fy­ing clin­i­cal tri­al re­sults sen­tenced to over 2 years in prison

4 years ago
Outsourcing
FDA+

So what ex­act­ly does Ver­i­ly do? A new deal with L'Oréal does­n't clear up much

4 years ago
Deals

As Hal Bar­ron steals the show, there’s no off po­si­tion on the John Maraganore switch; Dan­ny Bar-Zo­har makes an­oth­er ...

4 years ago
Peer Review

FDA lifts par­tial hold on Ku­ra's Phase Ib AML pro­gram as biotech re­dou­bles mit­i­ga­tion ef­forts

4 years ago
FDA+

Pub­li­cis Health snaps up R&D mar­ket­ing group track­ing re­al-world clin­i­cal tri­als – and pa­tient sen­ti­ment

4 years ago
Pharma
Marketing

A Sen­ate bill wants to even an 'un­lev­el play­ing field' for do­mes­tic, for­eign in­spec­tion drop-ins amid back­log

4 years ago
Manufacturing

Califf on ac­cel­er­at­ed ap­provals: Com­pa­nies need to do more work be­fore FDA says OK

4 years ago
FDA+

Psy­che­delics biotech set to go pub­lic via SPAC — push­ing IV form of psilo­cy­bin in­to PhI

4 years ago
Financing

A high-res mi­cro­scope the size of a toast­er? A mi­croscopy start­up earns big-name VC back­ers

4 years ago
Financing

Re­call re­port: Miss­ing la­bel, mi­cro­bial con­t­a­m­i­na­tion leads to re­call of two batch­es of two drugs

4 years ago
Manufacturing

Man­u­fac­tur­ing woes con­tin­ue for Au­robindo af­ter FDA's warn­ing let­ter

4 years ago
Manufacturing

Mer­ck com­mer­cial chief Frank Clyburn de­parts for CEO role at DuPont co-owned ad­di­tives com­pa­ny

4 years ago
Pharma
Marketing

Covid-19 man­u­fac­tur­ing roundup: New pro­duc­tion site opens in Africa; Sen­a­tor calls for test prices to be slashed

4 years ago
Manufacturing

Johns Hop­kins and lo­cal biotech team up for new man­u­fac­tur­ing site; New oral drug plat­form to help ac­cel­er­ate R&D ...

4 years ago
Manufacturing

'Al­tos was re­al­ly a once-in-a-life­time op­por­tu­ni­ty': Hal Bar­ron re­flects on his big move

4 years ago
Bioregnum
Cell/Gene Tx

Covid-19 roundup: Gener­ic Mer­ck pill to be made for low­er-in­come coun­tries; Gavi says it needs a $5B boost — ...

4 years ago
Coronavirus

Eu­ro­pean Par­lia­ment signs off on strength­en­ing drug reg­u­la­tor's abil­i­ty to tack­le short­ages

4 years ago
Pharma
FDA+

Zymeworks re­places half its C-suite, aims to lay off 25% of to­tal work­force as new CEO takes over

4 years ago
People
R&D

Faced with in­tense in­vestor back­lash, Unilever now says $68B is its fi­nal of­fer for GSK con­sumer health­care busi­ness

4 years ago
Deals

Fol­low­ing CRL, Re­vance says it's clear on in­struc­tions for re­sub­mit­ting BLA

4 years ago
Manufacturing

Next-gen CAR-T play­er steps on the gas with a $111M boost and a pos­i­tive glimpse at ear­ly da­ta

4 years ago
Financing

Or­biMed takes point on a new biotech launch, but al­most every­thing re­mains se­cret for now

4 years ago
Financing
Startups
First page Previous page 598599600601602603604 Next page Last page
A service from the Financial Times